loader
Please Wait
Applying Filters...

Athena Athena

X

Approved Drug Products containing 207946 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 JANSSEN PHARMS (6)

filter

01 SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR (6)

filter

01 RX (6)

filter

01 INVEGA HAFYERA (2)

02 INVEGA TRINZA (4)

filter

01 Yes (6)

URL Supplier Web Content
SUSPENSION, EXTEND...
273MG/0.875ML (273...
2015-05-18
207946
INVEGA TRINZA
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SUSPENSION, EXTEND...
1.560GM/5ML (312MG...
2021-08-30
207946
INVEGA HAFYERA
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SUSPENSION, EXTEND...
819MG/2.625ML (312...
2015-05-18
207946
INVEGA TRINZA
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SUSPENSION, EXTEND...
410MG/1.315ML (311...
2015-05-18
207946
INVEGA TRINZA
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SUSPENSION, EXTEND...
1.092GM/3.5ML (312...
2021-08-30
207946
INVEGA HAFYERA
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SUSPENSION, EXTEND...
546MG/1.75ML (312M...
2015-05-18
207946
INVEGA TRINZA
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 207946

Looking for FDA Orange Book APPLICATION 207946 6

19

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is PALIPERIDONE PALMITATE, with a corresponding application number 207946.

Regulatory Information RX

With a dosage strength 273MG/0.875ML (273MG/0.875ML)

Dosage Form Route SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR

Reference Listed Drug Yes

Approved since 2015-05-18

18

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is PALIPERIDONE PALMITATE, with a corresponding application number 207946.

Regulatory Information RX

With a dosage strength 1.560GM/5ML (312MG/ML)

Dosage Form Route SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR

Reference Listed Drug Yes

Approved since 2021-08-30

17

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is PALIPERIDONE PALMITATE, with a corresponding application number 207946.

Regulatory Information RX

With a dosage strength 819MG/2.625ML (312MG/ML)

Dosage Form Route SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR

Reference Listed Drug Yes

Approved since 2015-05-18

16

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is PALIPERIDONE PALMITATE, with a corresponding application number 207946.

Regulatory Information RX

With a dosage strength 410MG/1.315ML (311.79MG/ML)

Dosage Form Route SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR

Reference Listed Drug Yes

Approved since 2015-05-18

15

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is PALIPERIDONE PALMITATE, with a corresponding application number 207946.

Regulatory Information RX

With a dosage strength 1.092GM/3.5ML (312MG/ML)

Dosage Form Route SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR

Reference Listed Drug Yes

Approved since 2021-08-30

14

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is PALIPERIDONE PALMITATE, with a corresponding application number 207946.

Regulatory Information RX

With a dosage strength 546MG/1.75ML (312MG/ML)

Dosage Form Route SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR

Reference Listed Drug Yes

Approved since 2015-05-18

Post Enquiry
POST ENQUIRY